Literature DB >> 9754624

Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism.

H Ishiguro1, T Arinami, T Saito, S Akazawa, M Enomoto, H Mitushio, H Fujishiro, K Tada, Y Akimoto, H Mifune, S Shiozuka, H Hamaguchi, M Toru, H Shibuya.   

Abstract

Tyrosine hydroxylase is the rate-limiting step in the biosynthesis of catecholamines. To find variants in the tyrosine hydroxylase (TH) gene that are associated with schizophrenia, mood disorders, or alcohol dependence, all of the exons, the exon-intron boundaries, and the 5' promoter region of the TH gene were systematically screened for variants by single-strand conformation polymorphism analysis followed by direct nucleotide sequencing. Source DNAs for sequencing were from 88 Japanese patients comprised of 17 schizophrenics, 21 with mood disorders, and 50 alcoholics. Two novel variants, T-229A and Val468Met, were identified. Case-control comparisons demonstrated that distribution of these two variants were similar in the controls and the three psychiatric groups. Distributions of the previously reported Val81Met polymorphism alleles and the intron 1 TCAT repeat polymorphism alleles were similar in the four subject groups. Our study indicates that the TH gene is not likely to play a major role in the genetic predisposition to schizophrenia, mood disorders, or alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754624

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Transcription and epigenetic profile of the promoter, first exon and first intron of the human tyrosine hydroxylase gene.

Authors:  Gaetano Romano; Marcella Macaluso; Chiara Lucchetti; Lorraine Iacovitti
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

2.  Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems.

Authors:  Hao Jin; Gaetano Romano; Cheryl Marshall; Angela E Donaldson; Sokreine Suon; Lorraine Iacovitti
Journal:  J Cell Physiol       Date:  2006-04       Impact factor: 6.384

Review 3.  Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-06-02       Impact factor: 4.132

Review 4.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

5.  Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Matthew W Rice; Robert R Conley; Rosalinda C Roberts
Journal:  Front Psychiatry       Date:  2012-04-09       Impact factor: 4.157

6.  No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population.

Authors:  Hiroyuki Hibino; Mamoru Tochigi; Takeshi Otowa; Nobumasa Kato; Tsukasa Sasaki
Journal:  Behav Brain Funct       Date:  2006-10-03       Impact factor: 3.759

Review 7.  The association of insertions/deletions (INDELs) and variable number tandem repeats (VNTRs) with obesity and its related traits and complications.

Authors:  Yee-How Say
Journal:  J Physiol Anthropol       Date:  2017-06-14       Impact factor: 2.867

8.  Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism.

Authors:  Chul-Hyun Cho; Seung-Gul Kang; Jung-Eun Choi; Young-Min Park; Heon-Jeong Lee; Leen Kim
Journal:  Psychiatry Investig       Date:  2009-07-15       Impact factor: 2.505

9.  13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.

Authors:  T Teraishi; Y Ozeki; H Hori; D Sasayama; S Chiba; N Yamamoto; H Tanaka; Y Iijima; J Matsuo; Y Kawamoto; Y Kinoshita; K Hattori; M Ota; M Kajiwara; S Terada; T Higuchi; H Kunugi
Journal:  Transl Psychiatry       Date:  2012-05-22       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.